![](/images/general/no_picture/200_user.png)
Jon D Hoffmann
Examiner (ID: 9303, Phone: (571)272-9916 , Office: P/3746 )
Most Active Art Unit | 3746 |
Art Unit(s) | 3746 |
Total Applications | 82 |
Issued Applications | 44 |
Pending Applications | 0 |
Abandoned Applications | 38 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15360693
[patent_doc_number] => 20200016111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Prodrugs of Fumarates and Their Use in Treating Various Diseases
[patent_app_type] => utility
[patent_app_number] => 16/524498
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16524498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/524498 | Prodrugs of fumarates and their use in treating various diseases | Jul 28, 2019 | Issued |
Array
(
[id] => 14864587
[patent_doc_number] => 20190282535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => COMBINATION THERAPY OF A HIF-2-ALPHA INHIBITOR AND AN IMMUNOTHERAPEUTIC AGENT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/393793
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393793 | Combination therapy of a HIF-2-a inhibitor and an immunotherapeutic agent and uses thereof | Apr 23, 2019 | Issued |
Array
(
[id] => 14682239
[patent_doc_number] => 20190240234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/387233
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16387233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/387233 | Pharmaceutical composition for treatment of increased intraocular pressure | Apr 16, 2019 | Issued |
Array
(
[id] => 15035755
[patent_doc_number] => 20190328882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY
[patent_app_type] => utility
[patent_app_number] => 16/382533
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382533 | MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY | Apr 11, 2019 | Abandoned |
Array
(
[id] => 14403601
[patent_doc_number] => 20190167644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => AGENT FOR REDUCING VISCERAL FAT WEIGHT
[patent_app_type] => utility
[patent_app_number] => 16/270193
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270193 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | Feb 6, 2019 | Abandoned |
Array
(
[id] => 15813911
[patent_doc_number] => 10632112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Combination therapy for treatment of HBV infections
[patent_app_type] => utility
[patent_app_number] => 16/235210
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10241
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235210 | Combination therapy for treatment of HBV infections | Dec 27, 2018 | Issued |
Array
(
[id] => 16105497
[patent_doc_number] => 10695333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Pharmaceutical combination comprising LSZ102 and alpelisib
[patent_app_type] => utility
[patent_app_number] => 16/204471
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 10389
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204471 | Pharmaceutical combination comprising LSZ102 and alpelisib | Nov 28, 2018 | Issued |
Array
(
[id] => 14375141
[patent_doc_number] => 20190161483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => METHODS FOR USING FXR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/202637
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202637 | METHODS FOR USING FXR AGONISTS | Nov 27, 2018 | Abandoned |
Array
(
[id] => 13982293
[patent_doc_number] => 20190060304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => AZA-ARYL 1H-PYRAZOL-1-YL BENZENE SULFONAMIDES
[patent_app_type] => utility
[patent_app_number] => 16/170752
[patent_app_country] => US
[patent_app_date] => 2018-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16170752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/170752 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | Oct 24, 2018 | Issued |
Array
(
[id] => 14531493
[patent_doc_number] => 20190201367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/145703
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145703 | Prodrugs of fumarates and their use in treating various diseases | Sep 27, 2018 | Issued |
Array
(
[id] => 14621577
[patent_doc_number] => 20190224156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Methods of Treating an Overweight or Obese Subject
[patent_app_type] => utility
[patent_app_number] => 16/113436
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113436 | Methods of Treating an Overweight or Obese Subject | Aug 26, 2018 | Abandoned |
Array
(
[id] => 13551611
[patent_doc_number] => 20180327353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/046893
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046893 | SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF | Jul 25, 2018 | Abandoned |
Array
(
[id] => 13504613
[patent_doc_number] => 20180303849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/017805
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017805 | Pharmaceutical composition for treatment of increased intraocular pressure | Jun 24, 2018 | Issued |
Array
(
[id] => 13916547
[patent_doc_number] => 10202381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/014885
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31459
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014885 | Histone demethylase inhibitors | Jun 20, 2018 | Issued |
Array
(
[id] => 13287629
[patent_doc_number] => 10154987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Enalapril formulations
[patent_app_type] => utility
[patent_app_number] => 16/003994
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19964
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003994 | Enalapril formulations | Jun 7, 2018 | Issued |
Array
(
[id] => 15068245
[patent_doc_number] => 10463588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Cosmetic composition for anti-aging or alleviating skin redness, and medicinal composition for preventing and treating skin inflammatory diseases, containing compound inducing increase in expression of adiponectin
[patent_app_type] => utility
[patent_app_number] => 15/958936
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 10796
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/958936 | Cosmetic composition for anti-aging or alleviating skin redness, and medicinal composition for preventing and treating skin inflammatory diseases, containing compound inducing increase in expression of adiponectin | Apr 19, 2018 | Issued |
Array
(
[id] => 13234905
[patent_doc_number] => 10130636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => High dosage strength tablets of rucaparib
[patent_app_type] => utility
[patent_app_number] => 15/920643
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 5150
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920643 | High dosage strength tablets of rucaparib | Mar 13, 2018 | Issued |
Array
(
[id] => 12904555
[patent_doc_number] => 20180193360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 15/917106
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917106 | Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer | Mar 8, 2018 | Abandoned |
Array
(
[id] => 13944567
[patent_doc_number] => 10208039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/891927
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32144
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891927
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891927 | Histone demethylase inhibitors | Feb 7, 2018 | Issued |
Array
(
[id] => 14817117
[patent_doc_number] => 10405538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Platelet storage methods and compositions for same
[patent_app_type] => utility
[patent_app_number] => 15/873983
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 8799
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873983 | Platelet storage methods and compositions for same | Jan 17, 2018 | Issued |